1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Lip Cancer Global Clinical Trials Review, H1, 2014

Lip Cancer Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • GlobalData
  • -
  • 121 pages

Lip Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Lip Cancer Global Clinical Trials Review, H1, 2014" provides data on the Lip Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lip Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lip Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Lip Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lip Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Lip Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Lip Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Lip Cancer 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Drugs 26
Clinical Trial Overview of Top Institutes / Government 27
National Cancer Institute 27
Clinical Trial Overview of National Cancer Institute 27
University of Washington 30
Clinical Trial Overview of University of Washington 30
Roswell Park Cancer Institute 31
Clinical Trial Overview of Roswell Park Cancer Institute 31
Stanford University 32
Clinical Trial Overview of Stanford University 32
Ohio State University Comprehensive Cancer Center 33
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 33
The University of Chicago 34
Clinical Trial Overview of The University of Chicago 34
Case Comprehensive Cancer Center 35
Clinical Trial Overview of Case Comprehensive Cancer Center 35
University of Kentucky 36
Clinical Trial Overview of University of Kentucky 36
The Ohio State University 37
Clinical Trial Overview of The Ohio State University 37
Washington University School of Medicine 38
Clinical Trial Overview of Washington University School of Medicine 38
Five Key Clinical Profiles 39
Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 119
Secondary Research 119
About GlobalData 120
Contact Us 120
Disclaimer 120
Source 121

List of Tables
Lip Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 6
Lip Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lip Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lip Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Lip Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Lip Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Lip Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Lip Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Lip Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Lip Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lip Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lip Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Lip Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Lip Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Lip Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lip Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Lip Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Lip Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Lip Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Lip Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Lip Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Lip Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 27
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 30
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 31
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 32
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014* 33
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014* 34
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 35
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 36
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2014* 37
Lip Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 38

List of Figures
Lip Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Lip Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lip Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lip Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Lip Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Lip Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Lip Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Lip Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lip Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lip Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Lip Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Lip Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lip Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Lip Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Lip Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Lip Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 119

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025 Summary Myelofibrosis (MF) is a rare blood disorder, which is characterized by bone marrow fibrosis. Currently, there is ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.